| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.35 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |